| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 16571-657-10 | 16571-657 | HUMAN PRESCRIPTION DRUG | Cevimeline Hydrochloride | Cevimeline Hydrochloride | CAPSULE | ORAL | 20140617 | N/A | ANDA | ANDA203775 | Rising Pharma Holdings, Inc. | CEVIMELINE HYDROCHLORIDE | 30 mg/1 | 100 CAPSULE in 1 BOTTLE (16571-657-10) |
| 63629-9863-1 | 63629-9863 | HUMAN PRESCRIPTION DRUG | Cevimeline Hydrochloride | Cevimeline Hydrochloride | CAPSULE | ORAL | 20231027 | N/A | ANDA | ANDA203775 | Bryant Ranch Prepack | CEVIMELINE HYDROCHLORIDE | 30 mg/1 | 30 CAPSULE in 1 BOTTLE (63629-9863-1) |
| 63629-9863-2 | 63629-9863 | HUMAN PRESCRIPTION DRUG | Cevimeline Hydrochloride | Cevimeline Hydrochloride | CAPSULE | ORAL | 20231027 | N/A | ANDA | ANDA203775 | Bryant Ranch Prepack | CEVIMELINE HYDROCHLORIDE | 30 mg/1 | 60 CAPSULE in 1 BOTTLE (63629-9863-2) |
| 63629-9863-3 | 63629-9863 | HUMAN PRESCRIPTION DRUG | Cevimeline Hydrochloride | Cevimeline Hydrochloride | CAPSULE | ORAL | 20231027 | N/A | ANDA | ANDA203775 | Bryant Ranch Prepack | CEVIMELINE HYDROCHLORIDE | 30 mg/1 | 90 CAPSULE in 1 BOTTLE (63629-9863-3) |